Inventor · disambiguated record
Katja Prelle
Also filed as: PRELLE KATJA
7 granted patents·13 pending applications·6 citations·filing 2004–2014
73Inventor score
Top patents by PatentIndex Score
20 records- 0176US7846917B218-Methyl-19-norandrost-4-ene 17, 17-spiro ether (18-methyl-19-nor-20-spirox-4-en-3-one), and pharmaceutical products comprising the sameBAYER SCHERING PHARMA AG·Filed 2007·Granted Dec 7, 2010·4 cites·20 claims
- 0269US8623850B215, 16-methylene-17-(1′-propenyl)-17,3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivativeKLAR ULRICH·Filed 2008·Granted Jan 7, 2014·1 cites·23 claims
- 0364US8207150B217β-cyano-19-nor-androst-4-ene derivative, its use and medicaments comprising the derivativeKUHNKE JOACHIM·Filed 2008·Granted Jun 26, 2012·1 cites·10 claims
- 0456US2010311702A119-nor-steroid derivatives with a 15alpha, 16alpha-methylene group and a saturated 17, 17-spiro-lactone ring, use thereof, and medicaments containing said derivativesBAYER SCHERING PHARMA AKTEINGESELLSCHAFT·Filed 2008·Application pending·0 cites
- 0550US8937058B217-hydroxy-19-nor-21-carboxylic acid-steroid γ-lactone derivative, use thereof, and medicament containing the derivativeKLAR ULRICH·Filed 2008·Granted Jan 20, 2015·0 cites·11 claims
- 0650US2011130371A1C-ring-substituted pregn-4-ene-21,17-carbolactones, and pharmaceutical preparations comprising the sameBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 0749US9034856B217-(1′propenyl)-17-3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivativeKLAR ULRICH·Filed 2008·Granted May 19, 2015·0 cites·9 claims
- 0849US8987239B219-nor-steroid derivatives with a 15α,16α-methylene group and a saturated 17,17-spirolactone ring, use thereof, and medicaments containing said derivativesBAYER IP GMBH·Filed 2013·Granted Mar 24, 2015·0 cites·9 claims
- 0949US2011015162A115,16-Methylene-17-hydroxy-19-nor-21-carboxylic acid-steroid Y-lactone derivative, use thereof and medicinal products containing the derivativeBAYER SCHERING PHARMA AG·Filed 2008·Application pending·0 cites
- 1048US2009099250A1Benzocycloheptene derivatives as estrogens having selective activityWYRWA RALF·Filed 2008·Application pending·0 cites
- 1147US2010292184A117beta-cyano-19-androst-4-ene derivative, its use and medicaments comprising the derivativeBAYER SCHERING PHARMA AG·Filed 2008·Application pending·0 cites
- 1246US2007197488A1Prodrugs of ERbeta-selective substances, process for their production, and pharmaceutical compositions that contain these compoundsPETERS OLAF·Filed 2006·Application pending·0 cites
- 1342US2016262923A1Intrauterine delivery systemBAYER OY·Filed 2014·Application pending·0 cites
- 1442US2009029957A18-beta-substituted estratrienes as selectively active estrogensPETERS OLAF·Filed 2008·Application pending·0 cites
- 1541US2009048218A117Beta-CYANO-18A-HOMO-19-NOR-ANDROST-4-ENE DERIVATIVE, ITS USE AND MEDICAMENTS COMPRISING THE DERIVATIVEKUHNKE JOACHIM·Filed 2008·Application pending·0 cites
- 1640US8445469B218-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latterBOHLMANN ROLF·Filed 2005·Granted May 21, 2013·0 cites·20 claims
- 1739US2007078262A1Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis-regulating medicaments and method for the preparation thereofSCHERING AG·Filed 2004·Application pending·0 cites
- 1836US2015065472A1Intrauterine application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems, intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one, as well as the use thereof in contraception and gynaecological therapyBayer Pharma AG·Filed 2013·Application pending·0 cites
- 1936US2015119372A1Application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems in the treatment of menorrhagia, as well as intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one for treating uterine bleeding disordersBayer Pharma AG·Filed 2013·Application pending·0 cites
- 2035US2009029953A118-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latterBOHLMANN ROLF·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Katja Prelle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →